Fate Therapeutics Inc FATE:NASDAQ

Last Price$18.70Cboe Real-Time Last Sale as of 3:17PM ET 8/20/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.29(1.53%)
Bid (Size)$18.70 (200)
Ask (Size)$18.74 (200)
Day Low / High$18.50 - 19.02
Volume269.8 K

Insider Trends: Fate Therapeutics Insider Extends 90-Day Selling Trend

6:03PM ET 1/31/2019 MT Newswires
Dr Amir Nashat, Director, on Jan 29, 2019, sold 97,500 shares in Fate Therapeutics (FATE) for $1,380,795. Subsequent to the Form 4 filing with the SEC, Dr Nashat has indirect ownership of 1,526,203 shares of company stock, which has a market value of $22.5 million as of the prior-day closing price.

During the most recent 90-day period, previous to the date of this filing, there have been 14 insider transactions reported to the SEC for Fate Therapeutics. These transactions came from the activities of 5 individual insiders that resulted in a net disposition of 464,483 company shares. Relative to the preceding 90-day window of time, there was 1 transaction from 1 insider that resulted in the acquisition of 3,703,704 shares.

This is a lower level of transactions than the peer group average in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Within the peer group activity averaged 29.5 transactions per company, with company insiders acquiring on average 13,584 shares.

SEC Story Link http://www.sec.gov/Archives/edgar/data/1434316/000089924319002256/xslF345X03/doc4.xml